Zydus receives final approval from the USFDA for Voriconazole Tablets

25 May 2016 Evaluate

Zydus Cadila has received the final approval from the USFDA to market Voriconazole Tablets in strengths of 50 mg and 200 mg. The drug will be produced at the group’s formulations manufacturing facility at Baddi in Himachal Pradesh.

The estimated sales for Voriconazole Tablets which is used in the treatment of fungal infections, is $92.8 million, as per IMS (MATMarch 2016).

The group now has more than 100 approvals and has so far filed nearly 270 ANDAs since the commencement of the filing process in FY 2003-04.


Zydus Lifesciences Share Price

864.60 -3.20 (-0.37%)
19-Jan-2026 11:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.80
Dr. Reddys Lab 1167.55
Cipla 1380.40
Zydus Lifesciences 864.60
Lupin 2175.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×